Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents-Reference-Cited by-同舟云学术

Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents

Published:2018-01 Issue:1 Volume:1869 Page:78-84
ISSN:0304-419X
Container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

Author:

Santoni Matteo^ORCID,Romagnoli Emanuela^ORCID,Saladino Tiziana,Foghini Laura,Guarino Stefania,Capponi Marco,Giannini Massimo,Cognigni Paolo Decembrini,Ferrara Gerardo,Battelli Nicola

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Oncology

Reference97 articles.

1. Comprehensive molecular portraits of human breast tumours;Cancer Genome Atlas Network;Nature,2012

2. Basal vs. luminal A breast cancer subtypes: a matched case-control study using estrogen receptor, progesterone receptor, and HER-2 as surrogate markers;Ibrahim;Med. Oncol.,2009

3. Targeting epidermal growth factor receptor in triple negative breast cancer: new discoveries and practical insights for drug development;Costa;Cancer Treat. Rev.,2017

4. Molecular alterations in triple-negative breast cancer–the road to new treatment strategies;Denkert;Lancet,2017

5. Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance;Yu;Chin. J. Cancer Res.,2017

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of tumor-derived extracellular vesicle-shuttled lncRNA MALAT1 on proliferation, invasion and metastasis of triple-negative breast cancer by regulating macrophage M2 polarization via the POSTN/Hippo/YAP axis;Translational Oncology;2024-11

2. Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment;Cancer Drug Resistance;2024-09-13

3. Preparation and effects of functionalized liposomes targeting breast cancer tumors using chemotherapy, phototherapy, and immunotherapy;Journal of Nanobiotechnology;2024-09-12

4. Exosomes of immune cell origin and their therapeutic potential for tumors;VIEW;2024-09-02

5. Eravacycline improves the efficacy of anti-PD1 immunotherapy via AP1/CCL5 mediated M1 macrophage polarization in melanoma;Biomaterials;2024-09